Pyxis Oncology
PYXS
PYXS
73 hedge funds and large institutions have $59.7M invested in Pyxis Oncology in 2025 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 11 increasing their positions, 31 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
1% less funds holding
Funds holding: 74 → 73 (-1)
65% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 31
Holders
73
Holding in Top 10
1
Calls
$350K
Puts
–
Top Buyers
| 1 | +$2.62M | |
| 2 | +$1.53M | |
| 3 | +$1.32M | |
| 4 |
LP
Longaeva Partners
Chicago,
Illinois
|
+$1.12M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$929K |
Top Sellers
| 1 | -$6.05M | |
| 2 | -$1M | |
| 3 | -$540K | |
| 4 |
P8IP
Pier 88 Investment Partners
San Francisco,
California
|
-$478K |
| 5 |
Goldman Sachs
New York
|
-$219K |
